Semaglutide Telehealth Consultation: What to Expect, Step by Step

Quick answer

A semaglutide telehealth consultation is a medical visit with a US-licensed physician, conducted online. You complete a detailed health intake, the physician reviews your medical history, medications, and weight history, screens for contraindications, and then decides whether semaglutide is appropriate for you. Depending on your state and on what the standard of care requires, the visit is asynchronous (intake review plus messaging) or live video. As of September 2026, the federal rule that requires at least 1 in-person medical evaluation before an internet prescription reaches only controlled substances, and semaglutide is not one; the physician must still be licensed where you are located and meet the same standard of care as an in-person visit. A legitimate consultation can end without a prescription. The physician decides, not the platform.

*Key takeaways*

• The in-person rule of the Ryan Haight Act covers controlled substances, and semaglutide is not on the DEA's list of them.
• The physician must be licensed in the state where you are located at the time of the visit.
• Asynchronous care can meet the standard of care; a static online questionnaire on its own cannot, according to the Federation of State Medical Boards.
• A compounded preparation needs a valid prescription written for you as an identified individual patient.

What is a semaglutide telehealth consultation, really?

Telehealth has made GLP-1 care reachable for people far from an obesity-medicine clinic, but the word "consultation" gets stretched by some platforms into something closer to a checkout form. It should not be.

A real semaglutide telehealth consultation has the same clinical components as an in-person visit:

• A complete medical intake: current medications, allergies, diagnoses, surgical history, mental health history, and family history
• Weight and metabolic context: BMI, weight history, prior weight-loss attempts, relevant labs if available
• Contraindication screening: personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), the subject of the boxed warning in the prescribing information for FDA-approved semaglutide injection; prior serious allergic reactions; pancreatitis; pregnancy or plans to become pregnant; and interacting medications
• A licensed physician's judgment: a physician licensed in the state where you are located reviews everything and makes the prescribing decision

If a website lets you add semaglutide to a cart before any physician has reviewed your health information, that is not a consultation. That is a red flag.

What does the law require before semaglutide can be prescribed online?

Federal controlled-substance law does not reach semaglutide. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 added an internet rule at 21 U.S.C. 829(e): no controlled substance that is a prescription drug may be delivered, distributed, or dispensed by means of the internet without a valid prescription, meaning one issued by a practitioner who has conducted at least 1 in-person medical evaluation of the patient, or by a covering practitioner. Under 21 U.S.C. 802(6), a controlled substance is a drug included in schedule I, II, III, IV, or V. Semaglutide does not appear on the DEA's alphabetical list of controlled substances dated August 27, 2026, so that in-person requirement does not apply to it. It exempts semaglutide from nothing else.

Semaglutide is still a prescription drug. Under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a), the exemptions that allow a pharmacy to compound a drug apply when it is compounded for an identified individual patient based on a valid prescription order.

State rules decide most of the details. The Federation of State Medical Boards (FSMB) telemedicine policy, adopted in April 2022, puts licensure plainly: a physician must be licensed, or appropriately authorized, by the medical board of the state where the patient is located, because that is where the practice of medicine occurs. Prescriptions issued in a virtual setting are held to the same standards as those issued in person, and no appropriate physician-patient relationship exists when the identity of the physician may be unknown to the patient. Consent matters too: California requires the provider to tell you that care is delivered by telehealth and to obtain and document your consent first.

Your own state's law controls. For licensure across states, see telehealth across state lines, and for the wider process, our guide to how online GLP-1 prescriptions work.

Who qualifies for semaglutide through telehealth?

The prescribing information for the FDA-approved semaglutide injection for chronic weight management describes the studied population: its weight-management trials enrolled adults with a BMI of 30 or higher, or 27 to 29.9 with at least one weight-related condition such as dyslipidemia or hypertension, and a separate trial enrolled adults with type 2 diabetes and a BMI of 27 or higher. A compounded preparation is not FDA-approved for any use.

Telehealth physicians generally start from those same criteria, and our BMI calculator guide shows where you stand. But two things matter more than the number:

1. The physician makes the final call. BMI is a screening tool, not an approval code. Your full history can rule treatment in or out.
2. A "no" is a valid outcome. If your profile does not support treatment, a legitimate physician will say so and explain why. Platforms that promise approval before anyone reads your history are advertising the absence of medical judgment.

What will the physician ask, and why?

Each question below traces to the current prescribing information for FDA-approved semaglutide injection, revised June 2026, and applies whether your visit is live video or a written intake.

• Have you or a close relative had medullary thyroid carcinoma, or do you have MEN 2? The label's boxed warning covers thyroid C-cell tumors, and either history is a contraindication.
• Have you had a serious allergic reaction to semaglutide or any ingredient in the product? A prior serious hypersensitivity reaction, such as anaphylaxis or angioedema, is a contraindication.
• Have you had pancreatitis? Acute pancreatitis has been observed with GLP-1 receptor agonists, so the physician will explain warning signs such as persistent, severe abdominal pain.
• Have you had gallbladder problems? Treatment is associated with more gallstones and gallbladder inflammation.
• Do you take insulin or a sulfonylurea? The combination can raise the risk of low blood sugar.
• Do you have kidney problems, or become dehydrated easily? Kidney injury has been reported, mostly in people dehydrated by nausea, vomiting, or diarrhea.
• Do you have severe gastroparesis? The label says the medicine is not recommended in people with it.
• Do you have type 2 diabetes with diabetic eye disease? People with a history of diabetic retinopathy should be monitored.
• What is your resting heart rate? Treatment has been associated with increases in resting heart rate.
• Is surgery or a procedure with anesthesia or deep sedation coming up? Rare reports describe pulmonary aspiration during general anesthesia or deep sedation in people taking GLP-1 receptor agonists.
• Are you pregnant, breastfeeding, or planning a pregnancy? The label says weight loss offers no benefit during pregnancy and may cause fetal harm, and advises stopping at least 2 months before a planned pregnancy because of semaglutide's long half-life.
• Which oral medications do you take? Slower stomach emptying can affect how oral medicines are absorbed, and the label advises closer monitoring for those with a narrow therapeutic index.

What should you have ready before your consultation?

A complete file saves follow-up questions; it does not change the standard the physician applies. Gather:

• Your current height and weight
• Every prescription medicine, over-the-counter medicine, and supplement you take, with how much and how often
• Allergies, especially any past reaction to a GLP-1 medicine
• Diagnoses and past surgeries with approximate dates, including gallbladder, pancreas, kidney, or thyroid history
• Family history of thyroid cancer or MEN 2
• Any planned surgery, procedure, or sedation
• Recent lab results, blood pressure, and resting heart rate, if you have them
• Whether you are pregnant, breastfeeding, or planning a pregnancy
• The state where you will be during the visit, since licensure follows your location

Asynchronous or live video: why does your state matter?

Telehealth rules are set state by state. The FSMB policy says a physician-patient relationship may be established through synchronous (live) or asynchronous (store-and-forward) technology, without a prior in-person meeting, so long as the standard of care is met. It draws limits: prescribing based solely on a static online questionnaire is not acceptable, adaptive questionnaires must allow follow-up questions, and when the in-person standard would have required a physical examination, the physician must use images, live video, or other tools as needed.

California shows how one state writes this into law. Business and Professions Code section 2242 makes it unprofessional conduct to prescribe a dangerous drug, a term that includes any prescription-only drug, without an appropriate prior examination and a medical indication, and says that examination does not require a synchronous interaction and can be done through telehealth, including a questionnaire, if the standard of care is met. Section 2290.5 covers both live and store-and-forward telehealth and requires documented consent first.

Other states set their own rules, and they change. A legitimate provider tells you which format applies where you live. Check whether we serve your state on our states page.

What happens after the consultation?

If the physician prescribes compounded semaglutide, the prescription is written for you individually and sent to a state-licensed 503A compounding pharmacy, which prepares a patient-specific prescription. See 503A pharmacies and 503B outsourcing facilities for what that means.

How long does it take? No rule sets a visit length: an asynchronous review has no appointment to wait for, a live video visit follows the physician's schedule, and the physician may ask follow-up questions first. Our pricing page describes shipping as designed for 5 to 7 business days.

Compounded semaglutide is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any brand-name medication. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. If an FDA-approved product is the better clinical or financial fit for you, for example because your insurance covers one, an honest physician will tell you that too.

Once treatment starts:

• Know exactly how to measure your dose. The FDA has received adverse event reports, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, and it encourages patients to ask their provider or compounder how to measure and administer the intended dose. Your physician sets and adjusts the dose.
• Tell every clinician before surgery or deep sedation. The label instructs patients to do this because of the aspiration risk.
• Report problems. The FDA encourages patients to report adverse events or quality problems through its MedWatch program, as well as telling your physician.

Treatment does not end at delivery: a legitimate program keeps the physician involved through follow-up check-ins and dose decisions.

What are the red flags in a telehealth consultation?

• Approval promised before anyone reviews your history. A promised outcome means no real medical evaluation happened.
• No physician name or license you can verify. Your state medical board's lookup confirms a license; the free NPI Registry, a query-only database CMS updates daily, lets you search a provider by name. See how to verify a doctor's license.
• No questions about thyroid cancer history, pancreatitis, or pregnancy. These are core contraindication screens; skipping them falls short of the standard of care.
• Medication before consultation. Product shipped before any physician review.
• Hidden fees. Consultation, shipping, or "membership" charges that appear after you have paid the headline price.
• Semaglutide sodium or semaglutide acetate. The FDA says these salt forms are different active ingredients from those in the approved drugs and should not be used to compound semaglutide. Ask any provider which form its pharmacy uses.

What does a semaglutide telehealth consultation cost?

Consultation pricing varies by provider structure:

• Bundled: the consultation is included in the monthly plan price. This is the transparent model, because the number you see is the number you pay.
• Separate: the platform charges a consultation or membership fee on top of the medication price. Not inherently wrong, but the headline price understates the real cost.

Whatever provider you compare, ask before paying: "What is my total first-month cost and my total ongoing monthly cost, including every fee?" For the full market picture, see our compounded semaglutide cost breakdown.

*How the Majesta Health consultation works*

1. You complete the medical assessment.
2. A US-licensed physician reviews your file and decides whether treatment is appropriate.
3. If the physician approves treatment, a state-licensed 503A pharmacy prepares a patient-specific prescription.
4. Nothing is charged unless a physician approves treatment.

• Essential (compounded semaglutide injection): $179 for the first month, then $299 every 30 days.
• Performance (compounded tirzepatide injection): $339 for the first month, then $439 every 30 days.

Both plans use the bundled model: the published price is all-in, covering the physician review, the compounded medication, shipping, and support. The first-month price includes a $20 medical consultation fee paid through to your licensed physician. You can cancel anytime.

Enrollment is in early access: join the early access list and we will email you when enrollment opens. Plan details are on our pricing page, and our clinicians are on the care team page.

The Bottom Line

A semaglutide telehealth consultation should feel like real medicine delivered conveniently, not a sales funnel with a medical costume. The physician reviews your history, screens for contraindications, and makes an individual decision. Sometimes that decision is no, and a provider that can tell you no is exactly the kind you want when the answer is yes.

If you want to see whether semaglutide treatment makes sense for you, start with our medical assessment. Every treatment decision on Majesta Health is made by a US-licensed physician.

Take the medical assessment

Related guides

• Online GLP-1 prescription in 2026: the legitimate path
• Compounded semaglutide cost in 2026: the honest breakdown
• Meet the Majesta Health care team

This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved as final products. Medication is prescribed only if a licensed physician determines it is appropriate. Always consult a qualified healthcare provider about your own care. Prices are Majesta Health's published prices as of September 2026 and are subject to change.